Table 3.
CD4 count and viral load results of client C (CC)
| Dates | CD4 count (cells/mm3) | Dates | Viral load (copies/ml) |
|---|---|---|---|
| 04/07/2011 | 20 | 04/08/2016 | 39,356 drugs switched to second line |
| 07/06/2012 | 299 | 27/07/2017 | 12, 500 |
| 02/05/2013 | 269 | 12/07/2018 | 6,200 |
| 09/11/2013 | 218 | 07/03/2019 | 1,300 |
| 15/05/2014 | 103 | 02/01/2020 | 939 |
| 2015 | defaulted | 25/11/2021 | 94 |
| 05/04/2016 | 18 | 16/10/2022 | <20 |
| 04/08/2016 | 18 | ||
| 27/07/2017 | 301 | ||
| 12/07/2018 | 409 |
The data was sourced from the client records at presentation, initiation of therapy, and at transitioning to dolutegravir (DTG)